Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.

  • Isabell Witzel
  • Christine Schröder
  • Volkmar Müller
  • Hilke Zander
  • Michael Tachezy
  • Maike Henningsen
  • Fritz Jänicke
  • Karin Milde-Langosch

Abstract

Conflicting results have been reported about activated leukocyte cell adhesion molecule (ALCAM) expression in breast cancer and its prognostic value. Little is known about the role of ALCAM levels in the serum of breast cancer patients.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer6
ISSN0030-2414
StatusVeröffentlicht - 2012
pubmed 22555284